Skip to main content

World-class neurological care
with a personal approach

Misconceptions About Arteriovenous Malformations

Arteriovenous malformations (AVMs) are defects in the vascular system, more specifically between the arteries and veins. They’re most commonly found in the brain or spine. Despite the significant medical progress in understanding AVMs, there are several misconceptions that persist. Here are some of them:

  1. “All AVMs require treatment.” Not all AVMs require treatment. The decision to treat an AVM is complex and depends on various factors, including the patient’s age, the location and size of the AVM, the patient’s symptoms, and the overall health of the patient. In some cases, the risk of treatment may outweigh its potential benefits.
  2. “AVMs always cause symptoms.” Many people with brain AVMs experience no symptoms at all, and these malformations are often discovered incidentally during treatment for an unrelated medical condition. However, when symptoms do occur, they can include headaches, seizures, or neurological problems.
  3. “AVMs are hereditary.” The majority of AVMs are not associated with any known genetic syndromes and seem to occur sporadically. However, there are a few rare genetic conditions (like Hereditary Hemorrhagic Telangiectasia) that may include AVMs as part of their symptomatology.
  4. “If you have a brain AVM, you cannot lead a normal life.” Many individuals with AVMs lead normal or near-normal lives, especially if their AVMs are asymptomatic. However, the potential for rupture (which can lead to a hemorrhagic stroke) does mean that living with an AVM requires regular monitoring and, potentially, lifestyle modifications.
  5. “Surgery is the only treatment option for AVMs.” While surgery is one treatment option for AVMs, other treatments are also available. These include radiosurgery (a form of radiation therapy) and embolization (a procedure that uses a glue-like substance to block the abnormal blood vessels).
  6. “AVMs can regrow after treatment.” This is a partial misconception. While it’s true that in rare cases, particularly in children and adolescents, AVMs can regrow after treatment, this is not the norm. The risk of regrowth seems to decrease significantly a few years after successful treatment.
  7. “All AVMs will eventually rupture.” The risk of AVM rupture varies depending on several factors, including the size and location of the AVM, and the presence of aneurysms. Not all AVMs will rupture, and the annual risk is estimated to be around 1-3%.

These misconceptions underline the importance of reliable information and communication between healthcare providers and patients. Each patient’s situation is unique, and management decisions should be made based on individual circumstances.